Want to join the conversation?
For FY16, $COO expects revenue to grow about 6-7% pro forma versus previous outlook of 5.5-7.0%. For 4Q16, company expects CooperVision's revenue to grow about 5.0-7.5% in constant currency and CooperSurgical's revenue to grow about 5-8% pro forma. 4Q16 non-GAAP GM is expected to be slightly over 64% and FY16 GM is expected to be about 63%.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!